Page last updated: 2024-11-03

propranolol and Hyperlipoproteinemia

propranolol has been researched along with Hyperlipoproteinemia in 2 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Durrington, PN1
Brownlee, WC1
Large, DM1
Schauer, UJ1
Schauer, I1

Trials

1 trial available for propranolol and Hyperlipoproteinemia

ArticleYear
Short-term effects of beta-adrenoceptor blocking drugs with and without cardioselectivity and intrinsic sympathomimetic activity on lipoprotein metabolism in hypertriglyceridaemic patients and in normal men.
    Clinical science (London, England : 1979), 1985, Volume: 69, Issue:6

    Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Cholesterol; Cholesterol, HDL; Female; Half-Life; Hear

1985

Other Studies

1 other study available for propranolol and Hyperlipoproteinemia

ArticleYear
[Lipoprotein metabolism and beta receptor blockers].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1987, Apr-15, Volume: 42, Issue:8

    Topics: Adrenergic beta-Antagonists; Atenolol; Cholesterol, HDL; Humans; Hyperlipoproteinemias; Lipoproteins

1987